GALLBLADDER CANCER RECURRENT

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting GALLBLADDER CANCER RECURRENT:

# Drug Count
0 CISPLATIN 3
1 GEMCITABINE 2
2 GEMCITABINE HYDROCHLORIDE 2
3 PEMBROLIZUMAB 2
4 ASPIRIN 1
5 ASPIRIN 325 MG 1
6 ASPIRIN 81 MG 1
7 CAPECITABINE 1
8 DEUCRAVACITINIB 1
9 DURVALUMAB 1
See all common drugs associated with GALLBLADDER CANCER RECURRENT

GALLBLADDER CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEUCRAVACITINIB 1 0.0003
1 GOLIMUMAB 1 0.0001
2 DURVALUMAB 1 0.0000
3 CISPLATIN 3 0.0000
4 GEMCITABINE HYDROCHLORIDE 2 0.0000
5 PEMBROLIZUMAB 2 0.0000
6 TRASTUZUMAB 1 0.0000
7 CAPECITABINE 1 0.0000
8 TERIPARATIDE 1 0.0000
9 TOCILIZUMAB 1 0.0000
See all drugs enriched for association with GALLBLADDER CANCER RECURRENT